and ASA fitness grade of III or below) requiring left lateral sectionectomy (LLS) were assigned randomly to OLLS or LLLS within an enhanced recovery after surgery (ERAS) programme. All randomized patients, ward physicians and nurses were blinded to the procedure undertaken. A parallel prospective registry (open non-randomized (ONR) versus laparoscopic non-randomized (LNR)) was used to monitor patients who were not enrolled for randomization because of doctor or patient preference. The primary endpoint was time to functional recovery. Secondary endpoints were length of hospital stay (LOS), readmission rate, overall morbidity, composite endpoint of liver surgery-specific morbidity, mortality, and reasons for delay in discharge after functional recovery.
Introduction
The left lateral segments of the liver can be resected by both open and laparoscopic approaches. The latter has become increasingly popular after the Louisville Statement of 2008, where experts concluded that laparoscopic left lateral sectionectomy (LLS) was a safe and effective approach for the management of surgical liver disease in the hands of experienced hepatobiliary and laparoscopic surgeons 1 . Later reviews 2, 3 , based mainly on retrospective data, showed favourable clinical outcomes after laparoscopic resection. Studies 4, 5 specifically comparing open and laparoscopic LLS have hitherto been based on retrospective designs or with small sample size. A meta-analysis 6 of non-randomized studies showed a reduction in duration of operation, shorter overall length of hospital stay (LOS) and reduced morbidity after laparoscopic LLS. This difference in LOS was, however, associated with significant heterogeneity among the included studies.
Enhanced recovery after surgery (ERAS) programmes have been introduced in patients undergoing minor and major liver resections. Multiple studies 7 -15 have shown that these programmes are feasible, safe and effective in reducing median LOS in both open and laparoscopic resection. Data available at the time of design of this study also suggested that a further reduction in LOS after liver resection could be achieved when the observed delay between patient recovery and actual discharge was minimized, as reported for colonic resections 10, 16 . Day of discharge from hospital is dependent on multiple factors, including patient expectations, local discharge logistics and cultural differences between countries, hospitals and surgeons. LOS may therefore be considered an inappropriate endpoint for comparison of surgical interventions. Within the ERAS programme for liver surgery, a composite endpoint has been defined: time to functional recovery. This endpoint, representing medical readiness for discharge, consisted of clear and objectively measurable criteria. A patient was considered functionally recovered if they had a normal or decreasing serum bilirubin level, good pain control with oral analgesia only, tolerance of solid food, no intravenous fluid support and independent mobility at the preoperative level 10 . Functionally recovered patients were generally capable of performing activities of daily living independently and were independent of hospital care.
The aim of this study was to compare open and laparoscopic liver surgery in a randomized, controlled, multicentre and blinded setting, in which all patients received a standardized liver resection within a standardized perioperative care programme, based on a standardized recovery outcome measure. A parallel registry to the randomized controlled arms was created to study an uninterrupted series for external validity. The hypothesis was that in patients undergoing laparoscopic LLS (LLLS), time to functional recovery would be reduced by 2 days compared with that in those having open LLS (OLLS).
Methods
This study (ORANGE II) was designed as a double-blind RCT with a parallel prospective registry of patients who could not be randomized owing to patient or surgeon preference. Patients were eligible for inclusion in the randomization if they required a liver LLS for accepted indications, if they were men or non-pregnant, non-lactating women aged 18-80 years with a BMI of 18-35 kg/m 2 and an ASA grade of III or less. Exclusion criteria were: planned liver resection other than LLS, ASA grade above III, and underlying liver disease diagnosed before surgery.
Representatives of the ORANGE II study group from Maastricht University Medical Centre coordinated the trial and analysed the data. The study protocol was approved by medical ethics committees at each participating centre. Centres were approached by e-mail and could participate if laparoscopic and open liver surgery were performed on a routine basis and if an ERAS liver programme had been implemented. Fourteen European sites obtained ethical approval to enrol patients; 12 were located in the Netherlands, one in Germany and one in Italy. The study protocol was registered online at ClinicalTrials.gov (NCT00874224), and has been published 17 . The aim of the study was to compare LLLS with OLLS in terms of time to functional recovery (primary endpoint). The hypothesis was that time to functional recovery would be reduced by 2 days in patients undergoing LLLS.
Randomization and masking
Patients were approached for participation in the outpatient clinic. All provided written informed consent before preoperative assessment. They received information and counselling related to the study intervention, ERAS programme and other study-related procedures. Patients were assigned randomly before admission in a 1 : 1 ratio to either OLLS or LLLS. Randomization was performed by each local study coordinator using a web-based system (TENALEA ® ; FormsVision, Abcoude, intervention by the use of a large fixed abdominal dressing until postoperative day (POD) 3. Non-randomized patients were asked for permission to use their data. In doing so, they were assigned to the open non-randomized (ONR) or laparoscopic non-randomized (LNR) arm of the prospective registry, on the basis that this registry might increase the external validity of results obtained in the randomized study 18, 19 .
Procedures
The intraoperative surgical technique was not standardized; surgeons in participating centres were free to use their preferred technique and devices to gain intra-abdominal access, perform hepatic parenchymal transection and maintain vascular control. Surgeons in each participating centre performed the allocated intervention based upon availability. Medical centres with liver surgeons early in the laparoscopic learning curve were assisted during the procedure by an experienced proctoring laparoscopic hepatopancreatobiliary (HPB) surgeon. Perioperative care for all patients in the study was standardized according to the ERAS programme and the perioperative care provided was based on daily guidelines ( Table 1) .
Outcomes
The primary outcome measure of this study for both the randomized and parallel cohorts was time to functional recovery. A patient was considered functionally recovered when all of the following criteria were fulfilled: adequate pain control with oral analgesia only; restoration of mobility to an independent or preoperative level; absence of intravenous fluid administration; ability to eat solid foods; and normal or decreasing serum bilirubin level or international normalized ratio (INR). The evaluation of time to functional recovery started on POD 0 and was scored until discharge from hospital using a standard checklist and patient diary. Patients were considered ready for discharge when the primary endpoint had been met, although it was up to the local logistics of each centre to define the actual moment of discharge. The delay between time to functional recovery and actual discharge was recorded and reasons for this delay were obtained.
Postoperative pain was registered twice daily using the validated, verbally administered, 11-point (0-10) numerical rating scale (NRS-11) 20, 21 . Centres were free to provide either epidural or intravenous patient-controlled analgesia. No indwelling wound catheters were used in participating centres. Members of a specialized pain team asked patients to rate the intensity of their current pain on a scale from 0 (no pain) to 10 (worst possible pain). A score of 1-3 was considered to be mild, 4-6 moderate and 7-10 severe 22 .
To report the difference between preoperative and postoperative level of mobility, the ERAS Mobility Scale (EMS), derived from the Groningen Activity Restriction Scale 23 , was used. The EMS utilizes ten items of basic actions to compare the level of mobility before and after surgical intervention. When the patient reached the preoperative EMS level, or had a positive score for eight of ten items, they were considered independently mobile.
Fluid and solid food intake was monitored, and a normal tolerance was required before discharge. Tolerance was considered to be normal when oral intake of solid food was resumed and continued for at least 24 h.
At the time of design of the study it was decided to monitor the postoperative serum bilirubin concentration and INR to ensure that no patient was discharged with impaired liver function. Serum bilirubin levels and INR were measured before surgery and on POD 1 and 3.
Secondary outcomes were postoperative LOS, readmission rate, total morbidity according to the Dindo-Clavien classification 24 , composite endpoint of liver surgery-specific morbidity 25 , mortality, and reasons for delay in discharge after functional recovery.
Data collection and patient safety
Data were collected using both paper case report forms A baseline assessment of mobility was performed on the day of admission. Venous blood samples were drawn before and after surgery, on POD 1 and 3. During admission, surgical details, data on time to functional recovery and complications were collected with a patient diary, a milestone checklist and standardized adverse event forms. An independent Data and Safety Monitoring Board (DSMB) in the Netherlands evaluated the progress and quality of the trial, and examined safety endpoints for each consecutive group of 25 patients. Baseline characteristics and serious adverse events were listed and presented in an unblinded fashion. Recommendations made by the DSMB were communicated to the medical ethics review committee of Maastricht University Medical Centre and all participating centres.
Statistical analysis
Time to functional recovery was used as the primary endpoint. Owing to lack of data on the reduction in time to functional recovery after liver surgery in an ERAS programme, a decision was made to use LOS for the purpose of power calculation, because this approached the primary endpoint most accurately. Based on a retrospective analysis of 31 patients in both ERAS and non-ERAS settings, who had undergone LLS from 1990 to 2010, the mean(s.d.) value for postoperative LOS after LLS in Maastricht University Medical Centre was 6⋅0(2⋅7) days. Thus a reduction in time to functional recovery of 2 days seemed feasible.
At 90 per cent power and α = 0⋅05 (2-tailed), a sample size of 2 × 40 patients in the randomization arms would be sufficient to detect this difference (2-tailed testing was planned to allow detection of an (unexpected) increase in time to functional recovery after LLLS compared with OLLS, and to be consistent with the 2-sided confidence intervals to be reported). Assuming an expected withdrawal rate of 10 per cent or less, the participation of at least ten centres, and the required addition of one randomized patient per arm for every additional participating centre to compensate for the loss of degrees of freedom incurred in the data analysis (which takes centre and treatment × centre effects into account), a total sample size of 110 (2 × 55) was required. Patients were analysed according to the intention-to-treat principle, and analysis was performed with SPSS ® for Windows ® version 21⋅0 (IBM, Armonk, New York, USA). After each group of 25 included patients, a report was sent to the DSMB. An interim analysis was planned after randomization and completion of follow-up of 50 per cent of the total sample size. The DSMB provided the principal investigator with recommendations: no action needed, early stopping (due to clear benefit/harm of a treatment, futility, or new external evidence), extending recruitment or follow-up, stopping a single arm of the multi-arm trial, or sanctioning and/or proposing protocol changes.
Assumption of normality was checked using the Shapiro-Wilk test. Continuous numerical data were summarized by the median (i.q.r.) value per treatment arm. Analysis was performed with χ 2 or Fisher's exact tests for binary outcomes, and Mann-Whitney U or t tests for continuous outcomes, depending on their normality. For the primary outcome time to functional recovery α = 0⋅05 (2-tailed) and for the secondary outcomes α = 0⋅01 (2-tailed) were used to correct for multiple testing.
Post hoc analyses to assess milestones during recovery of patients and compliance with elements of the ERAS protocol were also performed. To describe the compliance with individual ERAS elements per study group and centre, an overall compliance and the between-centre range was used. Per element, an 80 per cent cut-off value was set to qualify as compliant. The outcome analyses were repeated with multiple linear regression to adjust for patient age, sex, ASA grade and centre effects. Differences between individual surgeons within the same centre with respect to time to functional recovery, LOS, and difference between time to functional recovery and LOS were also examined.
Results
From January 2010 to 1 July 2014, ten of 14 centres that had ethical approval recruited patients for this study. A total of 104 patients were assessed for eligibility and 97 were included (Fig. 1) . Only 29 participants were randomized: 14 to OLLS and 15 to LLLS. The remaining 68 patients were included in the prospective registry. Some five patients were excluded after randomization: four required a larger hepatic resection and surgery was postponed in one woman because of pregnancy. One patient in the open arm of the prospective registry was also excluded after a preoperative change of procedure. No 30-day drop-outs were observed in the RCT or prospective registry. A total of 91 patients (24 randomized and 67 prospective registry) were included in the intention-to-treat analysis.
The DSMB did not express any objections to continuation of the trial after the first two reports (October 2012 and April 2013). In the third report of January 2014, however, the DSMB expressed concerns about the ORANGE II study group, because of an accrual rate of 24 per cent in the RCT. In accordance with recommended criteria for accrual and scientific progress 26 , a trial should be closed if it is open for more than 24 months with an accrual rate of less than 25 per cent. Therefore, the DSMB advised continuation of the trial for a maximum of 6 months. Because enrolment remained slow, a decision was made by the investigators to stop the trial on 1 July 2014. (7), inflammatory lesions (2), echinococcosis (1), hepatic cyst (1), haemangioma (1). #Fisher's exact test, except **Mann-Whitney U test and † †χ 2 test (all 2-tailed). ‡ ‡Variable with normal distribution: Shapiro-Wilk P > 0⋅050; Mann-Whitney U test results are shown, but t test leads to the same conclusion. α = 0⋅01 for all baseline variables to correct for multiple testing. ‡ ‡ ‡Fisher's exact test, except § § §Mann-Whitney U test (both 2-tailed). ¶ ¶ ¶Variable with normal distribution: Shapiro-Wilk P > 0⋅050; Mann-Whitney U test results are shown, but t test leads to the same conclusion. α = 0⋅01 for all secondary outcomes to correct for multiple testing. 
Patient demographics and surgical outcome
Baseline patient characteristics ( Table 2 ) and surgical outcomes (Table 3) were distributed equally between the groups in the randomized part of the study (OLLS versus LLLS), as well as in the prospective registry (ONR versus LNR). There appeared to be more patients with a history of previous abdominal surgery in the LNR group and a Free oral fluids (30) 1 (8) 2 (15) 5 (9) Patient preference 2 of 10 (20) 2 (15) 0 (0) 2 (4) Unknown 1 of 10 (10) 1 (8) 3 (23) 15 (28) Values are median (i.q.r.) unless indicated otherwise; *values in parentheses are percentages. †One patient died in hospital and was never discharged. OLLS, open left lateral sectionectomy; LLLS, laparoscopic left lateral sectionectomy; ONR, open non-randomized left lateral sectionectomy; LNR, laparoscopic non-randomized left lateral sectionectomy; LOS, length of hospital stay. ‡Mann-Whitney U test, except §Fisher's exact test (both 2-tailed). ¶Variable with normal distribution: Shapiro-Wilk P > 0⋅050; Mann-Whitney U test results are shown, but t test leads to the same conclusion. α = 0⋅05 for primary outcome, and α = 0⋅01 for all secondary outcomes to correct for multiple testing. 24 No morbidity 7 (64) 12 (92) 11 (85) 47 (87)
Values in parentheses are percentages. OLLS, open left lateral sectionectomy; LLLS, laparoscopic left lateral sectionectomy; ONR, open non-randomized left lateral sectionectomy; LNR, laparoscopic non-randomized left lateral sectionectomy. *Ascites, postresectional liver failure, bile leakage, intra-abdominal haemorrhage, intra-abdominal abscess and operative mortality. †Persistent pain (2), hypertension (2), infected epidural insertion site (1), urinary tract infection (1), dyspnoea of unknown origin (1). ‡Fisher's exact test (2-tailed). α = 0⋅01 for all secondary outcomes to correct for multiple testing.
Table 6 Overall compliance with elements of the enhanced recovery after surgery protocol per study group RCT Registry OLLS (n = 11) LLLS (n = 13) ONR (n = 13) LNR (n = 54) Preoperative Counselling 100 (100-100) 100 (100-100) 100 (100-100) 100 (100-100) Minimal preoperative fasting 100 (100-100) 100 (100-100) 100 (100-100) 100 (100-100) No anxiolytic premedication 82 (0-100) 77 (0-100) 85 (0-100) 78 (33-100) Perioperative Thoracic epidural analgesia/i.v. PCA 100 (100-100) 100 (100-100) 100 (100-100) 100 (100-100) Prevention of hypothermia 100 (100-100) 100 (100-100) 100 (100-100) 100 (100-100) CVP monitoring ( 100 (100-100) 100 (100-100) 100 (100-100) 100 (100-100) Antibiotic prophylaxis 100 (100-100) 100 (100-100) 100 (100-100) 100 (100-100) POD 1-3 Daily review of discharge criteria 100 (100-100) 100 (100-100) 100 (100-100) 100 (100-100) Ileus prevention ( longer median duration of surgery in the LLLS group, but after correction for multiple testing these differences were not significant.
Primary outcome
Time to functional recovery did not differ significantly between OLLS and LLLS groups, or between ONR and LNR groups ( Table 4 ). In the OLLS group, the median time to functional recovery was 3 (3-5) days, compared with 3 (3-3) days in the LLLS group (P = 0⋅284). The same median time to functional recovery was found in the registry groups: 3 (3-3) days for ONR versus 3 (3-4) days for LNR (P = 0⋅529). Subanalysis of individual functional recovery criteria revealed quicker tolerance of solid food in favour of the LNR group (1 (1-1) days versus 2 (1-2) days in the ONR group; P = 0⋅002).
Secondary outcomes
Median LOS did not differ significantly following OLLS compared with LLLS: 4⋅5 (4-6) versus 4 (3-5) days respectively (P = 0⋅049) (note that α = 0⋅01 for secondary outcomes in view of multiple testing). Median LOS in the prospective registry was also comparable: 5 (4-7) days for ONR versus 4 (3-5) days for LNR (P = 0⋅064). The reasons for delayed discharge after functional recovery per group are shown in Table 4 . Overall 39, 18 and 10 per cent of the delay was logistical or medical in nature, or based on patient request, respectively. Overall morbidity was the same for open and laparoscopic procedures, with no significant differences between Dindo-Clavien complication severity grades 24 or the composite endpoint for liver surgery-related morbidity ( Table 5) .
A total of five patients developed major morbidity (grade III or above). One patient in the open arm of the RCT died after developing a pulmonary embolism and cardiac arrest. One randomized patient developed a wound infection after LLLS, which was re-explored under local anaesthesia. In the open arm of the registry, one patient required surgery after a postoperative intra-abdominal bleed with haemodynamic instability. In the laparoscopic arm of the registry, one patient was admitted to the ICU for postresectional liver failure, and one was readmitted and received percutaneous radiological drainage after developing an intra-abdominal abscess.
Compliance with the ERAS protocol
No group was fully compliant with all protocol items. The OLLS, LLLS, ONR and LNR groups were compliant (more than 80 per cent) with between 10 and 14 of the 22 ERAS elements ( Table 6 ). Postoperative epidural analgesia was provided to 82, 69, 77 and 65 of patients in the OLLS, LLLS, ONR and LNR groups respectively. No data were available to score the elements ileus prevention (laxatives) and provision of oral analgesia on POD 1.
Regression analyses
Repeating the outcome analyses with multiple linear regression to adjust for patient age, sex, ASA grade and centre effects essentially confirmed the results of the Mann-Whitney U tests. However, analysis of residuals showed a clear outlier in both the open surgery arm of the RCT and the registry with respect to the outcome LOS. Therefore, all analyses, non-parametric as well as regression, were repeated. Without those outliers, the new results increased both P values for LOS to greater than 0⋅100. Finally, owing to the very small sample size, differences between surgeons within the same centre could not be evaluated.
Discussion
This RCT comparing open and laparoscopic LLS in an ERAS setting was not able to reach a meaningful conclusion on time to functional recovery because it had to be stopped prematurely owing to poor recruitment. No difference in time to functional recovery was found after LLLS compared with OLLS in the randomized trial, but this analysis is underpowered. A prospective registry of all patients not randomized owing to surgeon or patient preference also failed to show a difference in functional recovery. Considering the secondary endpoints, no differences between surgical procedures were observed with regard to blood loss, duration of surgery, LOS, morbidity, reoperation, readmissions and mortality rates.
The main contributor to poor recruitment was individual surgeons' preference for the laparoscopic procedure. This lead to a preference : randomization ratio of almost 3 : 1. Clinical equipoise was assumed at the time of design and start of this study. Based on a worldwide survey among HPB surgeons, an RCT and prospective register comparing open and laparoscopic techniques was considered necessary 27 . The majority of participating centres in the study had indicated that they considered a trial to be feasible and were willing to randomize patients. It was on this basis that it was deemed not necessary to perform a feasibility study. It is clear, however, that clinical equipoise was no longer present during the recruitment period. A recent expert statement 28 from the International Consensus Conference for Laparoscopic Liver Resection held at Morioka, Japan, in 2014 stated that minor laparoscopic liver resection, including LLS, has become standard practice, and this evolving change in surgical attitudes is likely to have influenced the present study.
The slow accrual might also be related to the lower incidence of LLS than an anticipated 10 per cent of the total volume of liver resections. Replacement of LLS by parenchyma-saving strategies using metastasectomy or local ablation procedures may also have been a contributing factor to slow recruitment.
Despite these limitations, the study has several strengths. No RCT has compared open and laparoscopic liver surgery.
Other studies comparing open and laparoscopic LLS 4,5,29 -31 were of relatively small size and retrospective in nature. The addition of a prospective registry of patients who were not randomized owing to surgeon or patient preference was of value, reflecting daily practice in many units performing liver surgery 18, 19 .
In the present series of 67 LLLS and 24 OLLS procedures undertaken in conjunction with an ERAS programme, patients were functionally recovered after 3 days. Although median LOS tended to be slightly shorter in the laparoscopic groups, this difference was not significant, and the study was not powered to detect a difference in LOS. The clinical relevance of a difference of less than 1 day can be questioned. A delay to discharge after functional recovery was observed in all groups, and there is clearly the opportunity for a further reduction in LOS if discharge logistics could be optimized 14, 16 . Minimization of this gap between recovery and discharge could reduce hospital costs.
Lessons learned from this trial could prove valuable for the design and execution of future surgical trials. Surgical RCTs are often difficult to undertake successfully, and pose particular practical and methodological challenges 32 . Blinding is frequently difficult to perform, and care must be taken to choose an objectively measurable outcome 33 . The present study, however, confirmed the practicality of blinding patients through the use of large abdominal dressings 34, 35 . Double-blinding could not be guaranteed as ward physicians read operation details accidentally. A proctoring surgeon assisted surgeons in their learning curve to ensure quality. Regression analyses in this study revealed no influence of individual surgeons on the primary outcome, supporting the view that this approach may overcome the surgical learning curve as a confounder 32 . The timing of the conduct of a surgical trial is also important 32 . When a new technique is introduced, there is a window of opportunity to conduct a trial. Once surgeons believe the new intervention is superior, randomization becomes difficult. This surgeon preference was the major cause of failure to recruit to this RCT. It is important that investigators ensure the presence of clinical equipoise. To assess this adequately, a feasibility study seems generally advisable to generate objective evidence that the main trial will not fail, at least owing to a perceived lack of equipoise.
